Jinling Pharmaceutical Company Limited (000919.SZ) SHZ
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 4.94B |
| Enterprise Value | 3.61B |
| P/E Ratio | 66.74 |
| PEG Ratio | 0.43 |
| Price/Sales Ratio | 1.25 |
| Price/Book Ratio | 1.03 |
| Enterprise/Revenue | 0.92 |
| Enterprise/EBITDA | 15.68 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.02 |
| Operating Margin | 0.01 |
AD
Management Effectiveness
| Return On Assets | 0.01 |
| Return On Equity | 0.02 |
Income Statement
| Revenue | 3.2B |
| Revenue/Share | 5.07 |
| Gross Profit | 666.98M |
| EBITDA | 231.62M |
| Net Income | 53.91M |
| Diluted EPS | 0.09 |
Balance Sheet
| Total Cash | 1.49B |
| Total Cash/Share | 2.39 |
| Total Debt | 226.68M |
| Total Debt/Equity | 0.06 |
| Current Ratio | 3.93 |
| Book Value Per Share | 7.8 |
Price History
| 52-Week Change | -14.13 |
| 52-Week High | 9.8 |
| 52-Week Low | 5.67 |
| Moving Average 50 Days | 6.18 |
| Moving Average 200 Days | 7.13 |
Statistics
| Average Volume | 13.29M |
| Shares Outstanding | 621.92M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.1 |
| Trailing Annual Dividend Yield | 1.58 |
| Payout Ratio | 0.98 |
| Last Split Factor | 3:2 |
| Last Split Date | July 10, 2006 |
AD
